Overview
- Kaiser Permanente will halt all gender-affirming surgeries for minors nationwide beginning August 29, while continuing hormone therapy and puberty blockers.
- The nonprofit cited evolving executive orders, Centers for Medicare & Medicaid Services inquiries, Federal Trade Commission reviews and Department of Justice subpoenas as the catalyst for its decision.
- Stanford Medicine, Children’s Hospital Los Angeles, Connecticut Children’s and Yale New Haven Health have likewise suspended or reduced under-19 gender-affirming services in recent weeks.
- Major medical associations and nursing unions decried the pause as political interference in clinical care, warning it could harm transgender youth mental health.
- Advocacy organizations and state officials are pursuing legal and legislative measures to safeguard minors’ access to gender-affirming treatments.